WebJul 28, 2024 · We expect investors to focus on the sales performance of Novavax’s NVAX protein-based COVID-19 vaccine, its sole marketed product, when it r... WebApr 15, 2024 · Zacks Research analyst S. Ganoria now forecasts that the biopharmaceutical company will earn $1.95 per share for the year, up from their previous estimate of $1.87. …
Novavax: Q2 2024 Earnings Downgrade Confirms Worst Fears
WebAug 5, 2024 · Novavax will host its quarterly conference call today at 4:30 p.m. ET. The dial-in numbers for the conference call are (866) 652-5200 (Domestic) or (412) 317-6060 (International).... WebNov 8, 2024 · Novavax will host its quarterly conference call today at 4:30 p.m. ET. The dial-in numbers for the conference call are (833) 974-2381 (Domestic) or (412) 317-5774 (International). sm3t 2022
Novavax, Inc. 2024 Q2 - Results - Earnings Call Presentation
WebEarnings announcement* for NVAX: Feb 28, 2024. Novavax, Inc. is expected* to report earnings ... WebApr 4, 2024 · Investor inquiries. Shareholders seeking information can contact investor relations at (240) 268-2024 or email us at [email protected]. Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with … Stock Quote - Novavax Investor Relations Novavax creates transformational vaccines that help address some of the world’s … Events - Novavax Investor Relations Connect with Novavax. Find the addresses and phone numbers for all of our … Meet innovative vaccine technology from Novavax. Our biotech company prevents … SEC Filings - Novavax Investor Relations WebJul 28, 2024 · NVAX’s surprise record has been dismal so far, as its earnings missed expectations in each of the last four quarters. It has a trailing four-quarter negative earnings surprise of 184.49%, on... soldering with a propane torch